/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Exicure Inc Share Price Today: Live Updates & Key Insights

Exicure Inc share price today is $3.94, up -4.6%. The stock opened at $4.1 against the previous close of $4.13, with an intraday high of $4.1 and low of $4.1.

Exicure Inc Share Price Chart

style
pb-0

Exicure Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Exicure Inc Share Price Performance

$3.94 -0.046(-4.6%) XCUR at 13 Mar 2026 03:56 PM Biotechnology
Lowest Today 4.1
Highest Today 4.1
Today’s Open 4.1
Prev. Close 4.13
52 Week High 15.91
52 Week Low 3.10
Day’s Range: Low 4.1 High 4.1
52-Week Range: Low 3.10 High 15.91
1 day return -
1 Week return -0.72
1 month return -0.95
3 month return -28.54
6 month return +0.97
1 year return -68.68
3 year return +289.62
5 year return -94.49
10 year return -

Exicure Inc Institutional Holdings

The Carlyle Group Inc 4.42

Vanguard Group Inc 0.66

Geode Capital Management, LLC 0.46

Vanguard Institutional Extnd Mkt Idx Tr 0.45

UBS Group AG 0.29

Fidelity Extended Market Index 0.22

iShares Micro-Cap ETF 0.10

BlackRock Inc 0.09

NT Ext Equity Mkt Idx Fd - L 0.09

NT Ext Equity Mkt Idx Fd - NL 0.08

Fidelity Total Market Index 0.07

Vanguard Total Stock Mkt Idx Inv 0.06

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Fidelity Series Total Market Index 0.06

Fidelity Nasdaq Composite Index 0.05

Spartan Extended Market Index Pool F 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

Morgan Stanley - Brokerage Accounts 0.03

Tower Research Capital LLC 0.03

Spartan Total Market Index Pool G 0.03

Northern Trust Extended Eq Market Idx 0.03

1290 VT Micro Cap K 0.00

State St US Extended Mkt Indx NL Cl C 0.00

BNYM Mellon SL Market Completion UC1 0.00

SSgA U.S. Total Market Index Strategy 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Bank of America Corp 0.00

SBI Securities Co Ltd 0.00

Advisor Group Holdings, Inc. 0.00

BNP Paribas Arbitrage, SA 0.00

JPMorgan Chase & Co 0.00

Millennium Management LLC 0.00

Exicure Inc Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Exicure Inc Fundamentals

Market Cap 26.32 M

PB Ratio 3.8002

PE Ratio 0.0

Enterprise Value 22.25 M

Total Assets 15.06 M

Volume 5093

Exicure Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:28826000 28.8M, FY21:-483000 -0.5M, FY20:16613000 16.6M, FY19:1296000 1.3M

Annual Profit FY23:-1375000 -1.4M, FY22:28826000 28.8M, FY21:-483000 -0.5M, FY20:16613000 16.6M, FY19:1296000 1.3M

Annual Net worth FY23:-16914000 -16.9M, FY22:-2582000 -2.6M, FY21:-65782000 -65.8M, FY20:-24116000 -24.1M, FY19:-26744000 -26.7M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-128000 -0.1M, Q1/2025:-108000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-203000 -0.2M

Quarterly Net worth Q3/2025:-2437000 -2.4M, Q2/2025:-2621000 -2.6M, Q1/2025:3010000 3.0M, Q3/2024:-1091000 -1.1M, Q2/2024:-600000 -0.6M

About Exicure Inc & investment objective

Company Information Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Mr. Jungsoo Kim

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow